Provided by Tiger Fintech (Singapore) Pte. Ltd.

LandBridge Co. LLC

59.77
-0.0150-0.03%
Volume:135.04K
Turnover:8.09M
Market Cap:4.58B
PE:52.33
High:60.38
Open:59.75
Low:59.09
Close:59.78
52wk High:87.60
52wk Low:48.55
Shares:76.55M
Float Shares:25.34M
Volume Ratio:0.67
T/O Rate:0.53%
Dividend:0.40
Dividend Rate:0.67%
EPS(TTM):1.14
EPS(LYR):0.2758
ROE:17.57%
ROA:5.26%
PB:17.17
PE(LYR):216.66

Loading ...

Why small-caps just might be the stock market's new 'Magnificent Seven'

Dow Jones
·
Aug 26

LB Pharmaceuticals Files for IPO

Dow Jones
·
Aug 23

24/7 Market News: LIXTE Biotechnology Spotlight- Revisiting the “Too Much of a Good Thing” Strategy for LB-100

GlobeNewswire
·
Aug 19

LB Group's H1 Profit Drops 20%, Revenue Slips 3%

MT Newswires Live
·
Aug 19

LandBridge Is Maintained at Neutral by Piper Sandler

Dow Jones
·
Aug 15

Landbridge Co Llc : Piper Sandler Cuts Target Price to $55 From $70

THOMSON REUTERS
·
Aug 15

LandBridge Company LLC Announces Dual Listing on Newly Launched NYSE Texas

Reuters
·
Aug 14

Stock Track | LandBridge (LB) Plummets 5.42% as Q2 Earnings Miss Estimates and Guidance Cut

Stock Track
·
Aug 07

LandBridge Q2 EPS $0.24 Misses $0.38 Estimate, Sales $47.53M Miss $48.84M Estimate

Benzinga
·
Aug 07

LandBridge Company LLC Reports 83% Year-Over-Year Revenue Increase and $18.5 Million Net Income for Q2 2025

Reuters
·
Aug 07

Landbridge Company Llc Announces Second Quarter 2025 Results

THOMSON REUTERS
·
Aug 07

BUZZ-Energy companies gain on Trump's threats to buyers of Russian crude

Reuters
·
Aug 06

BRIEF-Landbridge Announces Long-Term Surface Use And Pore Space Reservation Agreement With Devon Energy

Reuters
·
Aug 06

LandBridge Secures 10-Year Pore Space Agreement with Devon Energy for New Mexico Delaware Basin

Reuters
·
Aug 06

Landbridge Co Llc - Devon Commits to 175,000 Bpd Minimum Volume

THOMSON REUTERS
·
Aug 06

Landbridge- Deal Reserves 300,000 Bpd Low-Pressure Pore Space Capacity on Landbridge Surface Acreage

THOMSON REUTERS
·
Aug 06

CervoMed Announces 32-Week Data from RewinD-LB Trial Extension Phase Showing Neflamapimod’s Sustained Effect on Slowing Clinical Progression in Patients with Dementia with Lewy Bodies and Associated Reduction in a Key Plasma Biomarker of Neurodegeneration

GlobeNewswire
·
Jul 28

CervoMed to Present New Data from Phase 2b RewinD-LB Study at AAIC 2025 and Host Conference Call on July 28, 2025

GlobeNewswire
·
Jul 25

BRIEF-Gotham City Estimates Landbridge Holdings Shares Are Worth No More $5 To $24 Per Share

Reuters
·
Jul 24

Landbridge Shares Down 5.3% at $49.8 After Gotham City Research Says Co's Shares Are Worth No More $5-$24 per Share

THOMSON REUTERS
·
Jul 24